MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517029007 A) filed by Relaxera Pharmazeutische Gesellschaft MBH & Co. Kg, Bensheim, Germany, on March 27, for 'immunosuppressive medicament and method of treatment.'
Inventor(s) include Dschietzig, Thomas Bernd.
The application for the patent was published on April 18, under issue no. 16/2025.
According to the abstract released by the Intellectual Property India: "Relaxin-2 for use as a broad-spectrum substitute of glucocorticoids, mineralocorticoids, corticosteroids and their analogues for treating tissue and endothelial injuries without incurring inducing gluconeogenesis, Cushing's syndrome and cushingoid adverse effects. Medicament and treatm...